[Acquired alpha-thalassemia in an 86-year-old patient with myelodysplastic syndrome]

Rev Med Interne. 2023 Feb;44(2):89-91. doi: 10.1016/j.revmed.2022.12.005. Epub 2023 Jan 14.
[Article in French]

Abstract

Background: Alpha thalassemia-myelodysplastic syndrome (ATMDS) is one of the possible complications related to the genetic instability typical of clonal hemopoietic disorders such as myelodysplastic syndromes (MDS). Hemoglobin H acquisition, which is hemoglobin without alpha chains and with 4 beta chains is the hallmark of this disease.

Observation: An 86-year-old male with chronic, microcytic anemia was referred due to a fall in his hemoglobin level. The blood smear was remarkable for intense anisocytoses and poikilocytosis. Bone marrow analysis was followed by a diagnosis of MDS with a good prognostic score. Peripheral blood coloration with brilliant cresyl blue showed "golf ball-like" erythrocytes. Hemoglobin electrophoresis is notable for the presence of H hemoglobin. The new generation sequencing confirmed the diagnosis of ATMDS showing a non-sense mutation in the gene ATRX.

Conclusion: The diagnosis of ATMDS should be considered in the presence of the association of MDS, microcytic anemia and marked blood smear abnormalities such as anisocytosis and poikilocytosis. A little less than 10% of all MDS are complicated by ATMDS.

Keywords: Acquired; Acquis; Alpha thalassemia; Alpha thalassémie; Case-report; Myelodysplastic syndrome; Observation; Syndrome myelodysplasique.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged, 80 and over
  • Humans
  • Male
  • Mutation
  • Myelodysplastic Syndromes* / complications
  • Myelodysplastic Syndromes* / diagnosis
  • Myelodysplastic Syndromes* / genetics
  • X-linked Nuclear Protein / genetics
  • alpha-Thalassemia* / complications
  • alpha-Thalassemia* / diagnosis

Substances

  • X-linked Nuclear Protein

Supplementary concepts

  • Alpha-Thalassemia Myelodysplasia Syndrome